Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral arterial intervention · New York | Peripheral arterial intervention · New Jersey | |
|---|---|---|
| Surgeons, 2024 | 97 | 55 |
| Medicare fee-for-service cases | 12,468 | 8,709 |
| Growth since 2019 (Medicare FFS) | −0.1%/yr | +2.3%/yr |
| Forecast cases (Medicare FFS) | 16,300 in 2030 | 12,700 in 2030 |
| Forecast growth | +4.6%/yr to 2030 | +6.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 6.5 | 8.0 |
| Medicare Advantage share | 57% | 45% |
| Out of hospital | 60% (+12 pts since 2019) | 77% (+34 pts since 2019) |
| Cases per surgeon | 129 | 158 |
| Top 10 surgeons' share | 43% | 62% |
| Surgeons growing | 13 | 10 |
| New since the base year | 22 | 16 |
| Likely to stop billing it | 23 by 2026 | 10 by 2026 |
| Forecast miss, 1 year (procedure) | 8% | 8% |
| Company payments per surgeon | $3,358 | $942 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.